More on Varian Medical Systems (VAR): Q1 comes in mixed, missing on the bottom line but beating...


More on Varian Medical Systems (VAR): Q1 comes in mixed, missing on the bottom line but beating on revenue. Oncology Systems and X-Ray Products businesses both grew 8% and 18% respectively Y/Y, with margins in line with expectations. The company lowers guidance for Q2 and FY13 however, now expecting Q2 EPS to be $0.98 - $1.03, versus the consensus of $1.04. For FY13, it anticipates EPS of $4.08 - $4.16. The Street view is for an EPS of $4.24. Shares -4.3% AH.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs